Ocumension Therapeutics’ $200.4 Million Initial Public Offering

Davis Polk advised the underwriters on the deal. Sidley Austin advised Ocumension Therapeutics on the deal. Ocumension Therapeutics completed its initial public offering on the Hong…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Michael Patrini

This content is for Standard 1 Year members only.
Login Join Now